Novelrad · raw details

Minimally-invasive Suturing for Vascular and Heart Defect Closure · Metzer · Founded 2019

active Pre-Funding ← back to profile

Highlights

IIA supported (ever)

About

Minimally-invasive Suturing for Vascular and Heart Defect Closure

Novelrad has developed a micro sewing machine that can deploy a range of continuous suture patterns, percutaneously, with a simple click of a button. The versatile suturing platform mimics the surgical ‘gold standard’ and can address multiple indications in the cardiovascular system and beyond.

The device deploys a multipoint purse string suture at the beginning of the procedure, thereby, enabling safe dilation and reliable closure at the end of the procedure.

The Novelrad VCD features an unprecedented range of bore sizes using a single device.

Identity

NameNovelrad
Slugnovelrad
Type / kindstartup
Source _idUiNs5KmDgN6aOAyO6slotG8otrFtZt4bgmXyIdW6cbAnebd7ZTdovw

Status

Statusactive
Last update2026-05-17

Location

HQ country codeIL
HQ cityMetzer
HQ addressMetzer, Israel

Web & social

Websitehttps://novelrad.com/
LinkedInhttps://www.linkedin.com/company/68817418
YouTubehttps://www.youtube.com/@novelradltd.8513

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
medical-devicessurgeonsvascularsurgery-tools

Funding

Total raised
Current stagePre-Funding

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}